oxygen-delivery nanoparticles cmpf Search Results


oxygen-delivery nanoparticles cmpf  (BioMimetic Therapeutics)
90
BioMimetic Therapeutics oxygen-delivery nanoparticles cmpf
Illustration of the biomimetic oxygen-delivery <t>nanoparticles</t> (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1
Oxygen Delivery Nanoparticles Cmpf, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/oxygen-delivery+nanoparticles+cmpf/oxygen+delivery+nanoparticles/pmc11887188-25-5-5
Average 90 stars, based on 1 article reviews
oxygen-delivery nanoparticles cmpf - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1

Journal: Journal of Nanobiotechnology

Article Title: Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors

doi: 10.1186/s12951-025-03257-6

Figure Lengend Snippet: Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells. 68 Ga-NOTA-GZP PET/CT imaging was performed to evaluate the combination treatment response in vivo. CmPF was injected intravenously into LLC xenografts followed by administration of the combination therapy. Tumor volume was measured to assess the therapeutic efficacy enhancement. PFTBA: perfluorotributylamine, HSA: human serum albumin, PF: HSA-PFTBA, CmPF: cancer cell membrane-coated HSA-doped PFTBA, PET/CT: positron emission tomography/computed tomography, Car: carboplatin, PD-1: anti-mouse PD-1

Article Snippet: Scheme 1 Illustration of the biomimetic oxygen-delivery nanoparticles (CmPF) used for homologous targeting and improving oxygen concentration within the tumor microenvironment, thereby enhancing the immunotherapy efficacy through improved activation of immune cells.

Techniques: Concentration Assay, Activation Assay, Positron Emission Tomography-Computed Tomography, Imaging, In Vivo, Injection, Drug discovery, Membrane, Positron Emission Tomography, Computed Tomography